Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen to Develop High-Throughput RNAi Tools as Part of Research Project with Institut Curie

NEW YORK, Oct. 10 (GenomeWeb News) - Qiagen will work with the Institut Curie of France to develop high-throughput RNA interference screening tools, the company said today.

 

The collaboration is part of Institut Curie's BioPhenics project, which aims to combine RNAi technology and phenotypic analysis for cancer research, using cell biology and microscopic imaging.

 

Qiagen will contribute siRNA design and its HiPerFect delivery reagent.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.